"The American Journal of Medicine" doesn't, one study published in it does. The title is "Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection". It brings no new information regarding Hydroxochloroquine, but instead claims other studies show enough benefits (while not being classical good quality data as usually required) to recommend it in their protocol. Also recommends zinc and azithromycin. Bit of a nothing burger IMO.